{
  "id": "626aeba1e764a53204000040",
  "type": "factoid",
  "question": "Which company developed Waylivra?",
  "ideal_answer": "Waylivra is being developed by Ionis Pharmaceuticals through its subsidiary company, Akcea Therapeutics.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31301033"
  ],
  "snippets": [
    {
      "text": "Volanesorsen (Waylivra\u00ae), an antisense oligonucleotide inhibitor of apolipoprotein CIII (apoCIII) mRNA, is being developed by Ionis Pharmaceuticals through its subsidiary company, Akcea Therapeutics, to treat familial chylomicronemia syndrome (FCS), hypertriglyceridemia and familial partial lipodystrophy (FPL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31301033",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Ionis Pharmaceuticals, Akcea Therapeutics"
}